Renosome Bio
Biotechnology Research • 
Newton, Massachusetts, United States • 1-10 Employees
Company overview
| Headquarters | 55 Chapel St, Newton, Massachusetts 02458, US |
| NAICS | 541714 |
| Keywords | Dermatology, Nephrology, Regenerative Medicine, Exosomes, Retinology |
| Founded | 2024 |
| Employees | 1-10 |
Key Contact at Renosome Bio
Adam Kievman
Founder/ CEO
About Renosome Bio
Renosome Bio is developing breakthrough medicines utilizing regenerative biology with the potential to reverse chronic diseases. We are applying our proprietary technology across multiple therapeutic areas to develop the next generation of transformative treatments.
$
Renosome Bio revenue & valuation
| Annual revenue | $256,665 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $821,328 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
C-Suite
Employees by Department
Renosome Bio has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
Renosome Bio has never raised funding before.
United Kingdom
Australia
CanadaFrequently asked questions
Renosome Bio is located in Newton, Massachusetts, US.
Renosome Bio was founded in 2024, making it 2 years old. The company has established itself as a significant player in its industry over this time.
Renosome Bio has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.
4.8
40,000 users
